Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) and Santarus, Inc. (NASDAQ:SNTS) Added to Growing Stock Report's NASDAQ Watch List.

New York, NY -- (SBWIRE) -- 03/05/2013 -- Growing Stock Report expands its NASDAQ Watch List adding Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) and Santarus, Inc. (NASDAQ:SNTS)

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) a biopharmaceutical company that focuses on developing and commercializing products to treat diseases associated with inflammation is currently up (+12.08%) on 1,876,560 shares traded. Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) is currently up (+34.69%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Watch List.

Click Here to find out what other Investors are saying about Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH)

Santarus, Inc. (NASDAQ:SNTS) a specialty biopharmaceutical company that engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists is currently up (+11.16%) on 1,588,673 shares traded after Santarus reported earnings that crushed Wall Street’s consensus. Santarus, Inc. (NASDAQ:SNTS) is currently up (+231.18%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Watch List.

Click Here to find out what other Investors are saying about Santarus, Inc. (NASDAQ:SNTS)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com